STONKWHISPER
← Back to Intel
Insider ActivityHALO

Torley Helen, PRESIDENT AND CEO, Director at HALOZYME THERAPEUTICS, INC., sold $276K of HALO

Updated Jun 20, 2026
Torley Helen PRESIDENT AND CEO, Director
HALOZYME THERAPEUTICS, INC. · $HALO
$276K Total Value
3,950 Shares Traded
$69.787 Price / Share
768,380 Shares Owned After
2026-05-13 Filing Date

Transaction Details

InsiderTorley Helen
TitlePRESIDENT AND CEO, Director
CompanyHALOZYME THERAPEUTICS, INC.
TickerHALO
Transaction TypeSale
Transaction Date2026-05-13
Shares Traded3,950
Price Per Share$69.787
Total Value$276K
Filed Date2026-05-13
Accession Number0001159036-26-000070

Ownership Context

Shares Owned After Transaction768,380
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001159036-26-000070

Other Insider Trades — HALO

Other Trades by Torley Helen

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for HALO — HALOZYME THERAPEUTICS, INC. →

Whisper Score — HALO

34.48
Murmurs
Current Whisper Score

See full analysis for HALO →

Track HALO insider activity in real time on The Wire →

Get alerts when Torley Helen files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 20, 2026 at 07:13 UTC

Want real-time data? Access The Wire for live sentiment tracking.